In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
A team of experts including local conservationist Budi Purwanto, snake handler Diaz Nugraha, and photographer Radu Frentiu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results